Kymera Therapeutics, Inc.
US ˙ NasdaqGM ˙ US5015751044

SecurityKYMR / Kymera Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership118,597 shares
Latest Disclosed Value $ 9,877,944
Citadel Advisors Llc ownership in KYMR / Kymera Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 118,597 shares of Kymera Therapeutics, Inc. (US:KYMR) valued at $9,877,944 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 159,865 shares of Kymera Therapeutics, Inc.. This represents a change in shares of -25.81% during the quarter. The current value of the position is $8,791,596 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (KYMR) in the form of stock options. The firm currently holds call options representing 27,200 of underlying shares valued at $2,265,488 USD and put options representing 9,900 of underlying shares valued at $824,571 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KYMR / Kymera Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KYMERA THERAPEUTICS COM 501575104 118,597 -41,268 -25.81 9,878 -20.60 0.0016
2026-02-17 2025-12-31 13F KYMERA THERAPEUTICS COM 501575104 159,865 118,042 282.24 12,439 425.52 0.0019
2025-11-14 2025-09-30 13F KYMERA THERAPEUTICS COM 501575104 41,823 -477,064 -91.94 2,367 -89.55 0.0004
2025-08-14 2025-06-30 13F KYMERA THERAPEUTICS COM 501575104 518,887 516,382 20,614.05 22,644 33,200.00 0.0039
2025-05-15 2025-03-31 13F KYMERA THERAPEUTICS COM 501575104 2,505 -56,062 -95.72 69 -97.11 0.0000
2025-02-14 2024-12-31 13F KYMERA THERAPEUTICS COM 501575104 58,567 -2,765 -4.51 2,356 -18.81 0.0004
2024-11-14 2024-09-30 13F KYMERA THERAPEUTICS COM 501575104 61,332 -92,325 -60.09 2,903 -36.72 0.0006
2024-08-14 2024-06-30 13F KYMERA THERAPEUTICS COM 501575104 153,657 -107,724 -41.21 4,587 -56.35 0.0009
2024-05-15 2024-03-31 13F KYMERA THERAPEUTICS COM 501575104 261,381 -110,062 -29.63 10,508 11.11 0.0020
2024-02-14 2023-12-31 13F KYMERA THERAPEUTICS COM 501575104 371,443 152,460 69.62 9,457 210.75 0.0019
2023-11-14 2023-09-30 13F KYMERA THERAPEUTICS COM 501575104 218,983 -60,599 -21.67 3,044 -52.65 0.0007
2023-08-14 2023-06-30 13F KYMERA THERAPEUTICS COM 501575104 279,582 279,364 128,148.62 6,428 107,016.67 0.0013
2023-05-15 2023-03-31 13F KYMERA THERAPEUTICS COM 501575104 218 -27,791 -99.22 6 -99.14 0.0000
2023-02-14 2022-12-31 13F KYMERA THERAPEUTICS COM 501575104 28,009 -23,610 -45.74 699 -37.81 0.0002
2022-11-14 2022-09-30 13F KYMERA THERAPEUTICS COM 501575104 51,619 51,619 1,124 0.0003
2022-08-15 2022-06-30 13F KYMERA THERAPEUTICS COM 501575104 0 -74,658 -100.00 0 -100.00
2022-05-16 2022-03-31 13F KYMERA THERAPEUTICS COM 501575104 74,658 40,860 120.89 3,160 47.25 0.0007
2022-02-14 2021-12-31 13F KYMERA THERAPEUTICS COM 501575104 33,798 -80,130 -70.33 2,146 -67.93 0.0004
2021-11-15 2021-09-30 13F KYMERA THERAPEUTICS Cmn 501575104 113,928 51,440 82.32 6,692 120.86 0.0014
2021-08-16 2021-06-30 13F KYMERA THERAPEUTICS COM 501575104 62,488 -62,237 -49.90 3,030 -37.49 0.0007
2021-05-21 2021-03-31 13F/A-1 KYMERA THERAPEUTICS COM 501575104 124,725 124,725 4,847 0.0012
2021-05-17 2021-03-31 13F KYMERA THERAPEUTICS COM 501575104 124,725 124,725 4,847 0.0012
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KYMERA THERAPEUTICS COM Call 27,200 142.86 2,265 160.05 n/a n/a n/a
2026-02-17 2025-12-31 13F KYMERA THERAPEUTICS COM Call 11,200 -50.44 871 -31.90 n/a n/a n/a
2025-11-14 2025-09-30 13F KYMERA THERAPEUTICS COM Call 22,600 -32.54 1,279 -12.46 n/a n/a n/a
2025-08-14 2025-06-30 13F KYMERA THERAPEUTICS COM Call 33,500 183.90 1,462 353.73 n/a n/a n/a
2025-05-15 2025-03-31 13F KYMERA THERAPEUTICS COM Call 11,800 -44.34 323 -62.21 n/a n/a n/a
2025-02-14 2024-12-31 13F KYMERA THERAPEUTICS COM Call 21,200 -13.82 853 -26.80 n/a n/a n/a
2024-11-14 2024-09-30 13F KYMERA THERAPEUTICS COM Call 24,600 8.85 1,164 72.70 n/a n/a n/a
2024-08-14 2024-06-30 13F KYMERA THERAPEUTICS COM Call 22,600 -31.10 675 -48.86 n/a n/a n/a
2024-05-15 2024-03-31 13F KYMERA THERAPEUTICS COM Call 32,800 102.47 1,319 219.90 n/a n/a n/a
2024-02-14 2023-12-31 13F KYMERA THERAPEUTICS COM Call 16,200 4.52 412 91.63 n/a n/a n/a
2023-11-14 2023-09-30 13F KYMERA THERAPEUTICS COM Call 15,500 -39.45 215 -63.44 n/a n/a n/a
2023-08-14 2023-06-30 13F KYMERA THERAPEUTICS COM Call 25,600 -18.47 589 -36.77 n/a n/a n/a
2023-05-15 2023-03-31 13F KYMERA THERAPEUTICS COM Call 31,400 -68.44 930 -62.55 n/a n/a n/a
2023-02-14 2022-12-31 13F KYMERA THERAPEUTICS COM Call 99,500 56.45 2,484 79.28 n/a n/a n/a
2022-11-14 2022-09-30 13F KYMERA THERAPEUTICS COM Call 63,600 -61.64 1,385 -57.58 n/a n/a n/a
2022-08-15 2022-06-30 13F KYMERA THERAPEUTICS COM Call 165,800 689.52 3,265 267.27 n/a n/a n/a
2022-05-16 2022-03-31 13F KYMERA THERAPEUTICS COM Call 21,000 517.65 889 311.57 n/a n/a n/a
2022-02-14 2021-12-31 13F KYMERA THERAPEUTICS COM Call 3,400 -8.11 216 -0.46 n/a n/a n/a
2021-11-15 2021-09-30 13F KYMERA THERAPEUTICS Cmn Call 3,700 217 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KYMERA THERAPEUTICS COM Put 9,900 -26.67 825 -21.52 n/a n/a n/a
2026-02-17 2025-12-31 13F KYMERA THERAPEUTICS COM Put 13,500 -2.88 1,050 33.59 n/a n/a n/a
2025-11-14 2025-09-30 13F KYMERA THERAPEUTICS COM Put 13,900 787 n/a n/a n/a
2025-08-14 2025-06-30 13F KYMERA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F KYMERA THERAPEUTICS COM Put 4,400 -20.00 120 -45.70 n/a n/a n/a
2025-02-14 2024-12-31 13F KYMERA THERAPEUTICS COM Put 5,500 -63.82 221 -69.26 n/a n/a n/a
2024-11-14 2024-09-30 13F KYMERA THERAPEUTICS COM Put 15,200 5.56 719 67.60 n/a n/a n/a
2024-08-14 2024-06-30 13F KYMERA THERAPEUTICS COM Put 14,400 48.45 430 10.28 n/a n/a n/a
2024-05-15 2024-03-31 13F KYMERA THERAPEUTICS COM Put 9,700 19.75 390 88.83 n/a n/a n/a
2024-02-14 2023-12-31 13F KYMERA THERAPEUTICS COM Put 8,100 102.50 206 274.55 n/a n/a n/a
2023-11-14 2023-09-30 13F KYMERA THERAPEUTICS COM Put 4,000 81.82 56 10.00 n/a n/a n/a
2023-08-14 2023-06-30 13F KYMERA THERAPEUTICS COM Put 2,200 -4.35 51 -26.47 n/a n/a n/a
2023-05-15 2023-03-31 13F KYMERA THERAPEUTICS COM Put 2,300 -96.42 68 -95.76 n/a n/a n/a
2023-02-14 2022-12-31 13F KYMERA THERAPEUTICS COM Put 64,300 337.41 1,605 401.25 n/a n/a n/a
2022-11-14 2022-09-30 13F KYMERA THERAPEUTICS COM Put 14,700 320 n/a n/a n/a
2022-05-16 2022-03-31 13F KYMERA THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F KYMERA THERAPEUTICS COM Put 3,900 -53.57 248 -49.70 n/a n/a n/a
2021-11-15 2021-09-30 13F KYMERA THERAPEUTICS Cmn Put 8,400 493 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.